These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 7356448

  • 1. Ganglioside accumulation in cultured skin fibroblasts from gangliosidosis patients.
    Pullarkat RK, Reha H, Beratis NG.
    Biochem Biophys Res Commun; 1980 Jan 15; 92(1):149-54. PubMed ID: 7356448
    [No Abstract] [Full Text] [Related]

  • 2. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.
    Raghavan S, Krusell A, Lyerla TA, Bremer EG, Kolodny EH.
    Biochim Biophys Acta; 1985 Apr 25; 834(2):238-48. PubMed ID: 3995063
    [Abstract] [Full Text] [Related]

  • 3. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J, Binns HJ.
    Clin Chim Acta; 1986 Apr 15; 156(1):41-9. PubMed ID: 2938852
    [Abstract] [Full Text] [Related]

  • 4. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?
    Rosengren B, Månsson JE, Svennerholm L.
    J Neurochem; 1987 Sep 15; 49(3):834-40. PubMed ID: 3612128
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assay.
    Bierfreund U, Lemm T, Hoffmann A, Uhlhorn-Dierks G, Childs RA, Yuen CT, Feizi T, Sandhoff K.
    Neurochem Res; 1999 Feb 15; 24(2):295-300. PubMed ID: 9972878
    [Abstract] [Full Text] [Related]

  • 9. Determinants in the uptake of lysosomal enzymes by cultured fibroblasts.
    Creek KE, Fischer HD, Sly WS.
    Methods Enzymol; 1983 Feb 15; 98():290-300. PubMed ID: 6230508
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides.
    Trasler J, Saberi F, Somani IH, Adamali HI, Huang JQ, Fortunato SR, Ritter G, Gu M, Aebersold R, Gravel RA, Hermo L.
    Endocrinology; 1998 Jul 15; 139(7):3280-8. PubMed ID: 9645704
    [Abstract] [Full Text] [Related]

  • 11. Ganglioside-composition of brain in Tay-Sachs disease: increased amounts of GD2 and N-acetyl-beta-D-galactosaminyl GD1a ganglioside.
    Iwamori M, Nagai Y.
    J Neurochem; 1979 Mar 15; 32(3):767-77. PubMed ID: 430057
    [No Abstract] [Full Text] [Related]

  • 12. The gangliosidoses: comparative features and research applications.
    Baker HJ, Reynolds GD, Walkley SU, Cox NR, Baker GH.
    Vet Pathol; 1979 Nov 15; 16(6):635-49. PubMed ID: 116415
    [Abstract] [Full Text] [Related]

  • 13. Classification of disorders of GM2 ganglioside hydrolysis using 3H-GM2 as substrate.
    Novak A, Callahan JW, Lowden JA.
    Biochim Biophys Acta; 1994 Mar 02; 1199(2):215-23. PubMed ID: 8123671
    [Abstract] [Full Text] [Related]

  • 14. Metabolism of Glycosphingolipids and Their Role in the Pathophysiology of Lysosomal Storage Disorders.
    Ryckman AE, Brockhausen I, Walia JS.
    Int J Mol Sci; 2020 Sep 19; 21(18):. PubMed ID: 32961778
    [Abstract] [Full Text] [Related]

  • 15. Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses.
    Utz JR, Crutcher T, Schneider J, Sorgen P, Whitley CB.
    Mol Genet Metab; 2015 Feb 19; 114(2):274-80. PubMed ID: 25557439
    [Abstract] [Full Text] [Related]

  • 16. [Identification of GM2-gangliosidosis using an in vitro loading test].
    Akhunov VS, Krasnopol'skaia KD.
    Vopr Med Khim; 1987 Feb 19; 33(4):115-9. PubMed ID: 3116767
    [Abstract] [Full Text] [Related]

  • 17. Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling.
    Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL.
    Hum Mol Genet; 2002 May 15; 11(11):1343-50. PubMed ID: 12019216
    [Abstract] [Full Text] [Related]

  • 18. Identification of the accumulated ganglioside.
    Svennerholm L.
    Adv Genet; 2001 May 15; 44():33-41. PubMed ID: 11596994
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Brain ceramide hexosides in Tay-Sachs disease and generalized gangliosidosis (GM1-gangliosidosis).
    Suzuki K, Chen GC.
    J Lipid Res; 1967 Mar 15; 8(2):105-13. PubMed ID: 14564716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.